Biblio

Export 1093 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Keyword is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
J
T. Jonsson, Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., Hoyte, K., Gustafson, A., Liu, Y., Lu, Y., Bhangale, T., Graham, R. R., Huttenlocher, J., Bjornsdottir, G., Andreassen, O. A., Jönsson, E. G., Palotie, A., Behrens, T. W., Magnusson, O. T., Kong, A., Thorsteinsdottir, U., Watts, R. J., and Stefansson, K., A mutation in APP protects against Alzheimer's disease and age-related cognitive decline., Nature, vol. 488, no. 7409, pp. 96-9, 2012.
T. Rivasseau Jonveaux and Fescharek, R., When Art Meets Gardens: Does It Enhance the Benefits? The Nancy Hypothesis of Care for Persons with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 885-898, 2018.
T. Rivasseau Jonveaux and Fescharek, R., When Art Meets Gardens: Does It Enhance the Benefits? The Nancy Hypothesis of Care for Persons with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 885-898, 2018.
P. Joussain, Bessy, M., Fournel, A., Ferdenzi, C., Rouby, C., Delphin-Combe, F., Krolak-Salmon, P., and Bensafi, M., Altered Affective Evaluations of Smells in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
P. Jul, Volbracht, C., de Jong, I. E. M., Helboe, L., Elvang, A. Brandt, and Pedersen, J. Torleif, Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model., J Alzheimers Dis, vol. 49, no. 3, pp. 783-95, 2016.
N. - Y. Jung, Han, C. E., Kim, H. Jin, Yoo, S. Wook, Kim, H. - J., Kim, E. - J., Na, D. L., Lockhart, S. N., Jagust, W. J., Seong, J. - K., and Seo, S. Won, Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 1125-35, 2016.
N. - Y. Jung, Han, C. E., Kim, H. Jin, Yoo, S. Wook, Kim, H. - J., Kim, E. - J., Na, D. L., Lockhart, S. N., Jagust, W. J., Seong, J. - K., and Seo, S. Won, Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 1125-35, 2016.
K
N. Kandiah, Wang, V., Lin, X., Nyu, M. Mei, Lim, L., Ng, A., Hameed, S., and Wee, H. Lin, Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost., J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score., J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
N. Kandiah, Wang, V., Lin, X., Nyu, M. Mei, Lim, L., Ng, A., Hameed, S., and Wee, H. Lin, Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost., J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score., J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
N. Kandiah, Wang, V., Lin, X., Nyu, M. Mei, Lim, L., Ng, A., Hameed, S., and Wee, H. Lin, Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost., J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.
D. Kapogiannis and Mattson, M. P., Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease., Lancet Neurol, vol. 10, no. 2, pp. 187-98, 2011.
I. Karakis, Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G., DeCarli, C., Vasan, R. S., Wang, T. J., Himali, J. J., Annweiler, C., and Seshadri, S., Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study., J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
K. Katisko, Haapasalo, A., Koivisto, A., Krüger, J., Hartikainen, P., Korhonen, V., Helisalmi, S., Herukka, S. - K., Remes, A. M., and Solje, E., Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration., J Alzheimers Dis, vol. 62, no. 2, pp. 789-794, 2018.
P. G. Kehoe, Blair, P. S., Howden, B., Thomas, D. L., Malone, I. B., Horwood, J., Clement, C., Selman, L. E., Baber, H., Lane, A., Coulthard, E., Passmore, A. Peter, Fox, N. C., Wilkinson, I. B., and Ben-Shlomo, Y., The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial., J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
C. M. Keith, Haut, M. W., Teixeira, C. Vieira Lig, Mehta, R. I., Phelps, H., Ward, M., Miller, M., R Navia, O., Coleman, M. M., Marano, G., Wang, X., Pockl, S., Rajabalee, N., Scarisbrick, D. M., McCuddy, W. T., D'Haese, P. - F., Rezai, A., and Wilhelmsen, K., Memory consolidation, temporal and parietal atrophy, and metabolism in amyloid-β positive and negative mild cognitive impairment., J Alzheimers Dis, vol. 102, no. 3, pp. 778-791, 2024.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials., J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials., J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
E. M. Khedr, Omeran, N., Ramadan, H. Karam- Alla, Ahmed, G. K., and Abdelwarith, A. M., Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment., J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
M. Rafi Khezri, Ghasemnejad-Berenji, M., and Moloodsouri, D., The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?, J Alzheimers Dis, vol. 92, no. 2, pp. 391-393, 2023.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
J. Kida, Nemoto, K., Ikejima, C., Bun, S., Kakuma, T., Mizukami, K., and Asada, T., Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study., J Alzheimers Dis, vol. 51, no. 2, pp. 405-15, 2016.
S. Kim, Nho, K., Ramanan, V. K., Lai, D., Foroud, T. M., Lane, K., Murrell, J. R., Gao, S., Hall, K. S., Unverzagt, F. W., Baiyewu, O., Ogunniyi, A., Gureje, O., Kling, M. A., P Doraiswamy, M., Kaddurah-Daouk, R., Hendrie, H. C., and Saykin, A. J., Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians., J Alzheimers Dis, vol. 49, no. 4, pp. 991-1003, 2016.

Pages